Challenges for management of immune thrombocytopenia during COVID-19 pandemic.
作者信息
Sahu Kamal Kant, Siddiqui Ahmad Daniyal, Rezaei Nima, Cerny Jan
机构信息
Division of Hematology and Oncology, Department of Medicine, Saint Vincent Hospital, Worcester, Massachusetts.
Division of Immunology, Research Center for Immunodeficiencies, Children's Medical Center, University of Medical Sciences, Tehran, Iran.
出版信息
J Med Virol. 2020 Nov;92(11):2277-2282. doi: 10.1002/jmv.26251. Epub 2020 Jul 11.
Abstract
摘要
相似文献
1
Challenges for management of immune thrombocytopenia during COVID-19 pandemic.2019冠状病毒病大流行期间免疫性血小板减少症的管理挑战
J Med Virol. 2020 Nov;92(11):2277-2282. doi: 10.1002/jmv.26251. Epub 2020 Jul 11.
2
Long-term reduction in the incidence of aplastic anemia and immune thrombocytopenia during the COVID-19 pandemic.新冠疫情期间再生障碍性贫血和免疫性血小板减少症发病率的长期降低。
Haematologica. 2023 Sep 1;108(9):2546-2550. doi: 10.3324/haematol.2022.282351.
3
Coronavirus disease associated immune thrombocytopenia: Causation or correlation?冠状病毒病相关免疫性血小板减少症：因果关系还是相关性？
J Microbiol Immunol Infect. 2021 Jun;54(3):531-533. doi: 10.1016/j.jmii.2020.08.006. Epub 2020 Aug 18.
4
Evans syndrome and immune thrombocytopenia in two patients with COVID-19.两名新冠肺炎患者并发伊文氏综合征和免疫性血小板减少症。
J Med Virol. 2021 May;93(5):2642-2644. doi: 10.1002/jmv.26906. Epub 2021 Mar 9.
5
Immune thrombocytopenia flare with mild COVID-19 infection in pregnancy: A case report.妊娠期轻度新型冠状病毒肺炎感染伴免疫性血小板减少症发作：一例报告
Br J Haematol. 2020 Aug;190(3):e146-e148. doi: 10.1111/bjh.16928. Epub 2020 Jun 30.
6
Immune Thrombocytopenia Secondary to COVID-19 Infection.新型冠状病毒肺炎感染继发免疫性血小板减少症
Isr Med Assoc J. 2021 Jun;23(6):342-343.
7
Bioinformatic Analysis Underpinning the Frequent Occurrence of Immune Thrombocytopenic Purpura in COVID-19 Patients.支持 COVID-19 患者频繁发生免疫性血小板减少性紫癜的生物信息学分析。
Isr Med Assoc J. 2022 May;24(5):320-326.
8
Clinical characteristics, management and outcome of COVID-19-associated immune thrombocytopenia: a French multicentre series.新型冠状病毒肺炎相关免疫性血小板减少症的临床特征、管理及结局：一项法国多中心研究系列
Br J Haematol. 2020 Aug;190(4):e224-e229. doi: 10.1111/bjh.17024. Epub 2020 Aug 4.
9
Immune thrombocytopenic purpura in pregnancy: a reappraisal of obstetric management and outcome.妊娠期免疫性血小板减少性紫癜：产科管理与结局的重新评估
J Reprod Med. 2011 Mar-Apr;56(3-4):163-8.
10
Immune thrombocytopenia following multisystem inflammatory syndrome in children (MIS-C) - a case series.儿童多系统炎症综合征（MIS-C）后的免疫性血小板减少症——病例系列
Pediatr Hematol Oncol. 2021 Oct;38(7):663-668. doi: 10.1080/08880018.2021.1917737. Epub 2021 May 5.
引用本文的文献
1
Mental Healthcare in Pediatrics During the COVID-19 Pandemic: A Call for International Public Health Action.儿科心理健康保健在 COVID-19 大流行期间：呼吁国际公共卫生行动。
Adv Exp Med Biol. 2024;1458:19-34. doi: 10.1007/978-3-031-61943-4_2.
2
Use of thrombopoietin receptor agonists in adults with immune thrombocytopenia: a systematic review and Central European expert consensus.成人免疫性血小板减少症中血小板生成素受体激动剂的应用：系统评价和中欧专家共识。
Ann Hematol. 2023 Apr;102(4):715-727. doi: 10.1007/s00277-023-05114-8. Epub 2023 Feb 24.
3
Computed tomography scan in COVID-19: a systematic review and meta-analysis.新型冠状病毒肺炎的计算机断层扫描：一项系统综述和荟萃分析。
Pol J Radiol. 2022 Jan 5;87:e1-e23. doi: 10.5114/pjr.2022.112613. eCollection 2022.
4
Assessment and Management of Immune Thrombocytopenia (ITP) in the Emergency Department: Current Perspectives.急诊科免疫性血小板减少症（ITP）的评估与管理：当前观点
Open Access Emerg Med. 2022 Jan 29;14:25-34. doi: 10.2147/OAEM.S331675. eCollection 2022.
5
Frequently Relapsing Post-COVID-19 Immune Thrombocytopenia.新型冠状病毒肺炎后频繁复发的免疫性血小板减少症
SN Compr Clin Med. 2021;3(12):2389-2392. doi: 10.1007/s42399-021-01019-7. Epub 2021 Jul 20.
6
Platelets in the perspective of COVID-19; pathophysiology of thrombocytopenia and its implication as prognostic and therapeutic opportunity.从 COVID-19 的角度看血小板；血小板减少症的病理生理学及其作为预后和治疗机会的意义。
Int Immunopharmacol. 2021 Oct;99:107995. doi: 10.1016/j.intimp.2021.107995. Epub 2021 Jul 21.
7
Real-world Experience of Rituximab in Immune Thrombocytopenia.利妥昔单抗治疗免疫性血小板减少症的真实世界经验
Indian J Hematol Blood Transfus. 2021 Jul;37(3):404-413. doi: 10.1007/s12288-020-01351-3. Epub 2021 Jan 1.
8
Interferon therapy in patients with SARS, MERS, and COVID-19: A systematic review and meta-analysis of clinical studies.干扰素治疗 SARS、MERS 和 COVID-19 患者：临床研究的系统评价和荟萃分析。
Eur J Pharmacol. 2021 Sep 5;906:174248. doi: 10.1016/j.ejphar.2021.174248. Epub 2021 Jun 12.
9
Nutrition and Immunity in COVID-19.新型冠状病毒肺炎中的营养与免疫。
Adv Exp Med Biol. 2021;1318:485-497. doi: 10.1007/978-3-030-63761-3_28.
10
COVID-19 in Patients with Cancer.癌症患者中的 COVID-19。
Adv Exp Med Biol. 2021;1318:315-331. doi: 10.1007/978-3-030-63761-3_18.
本文引用的文献
1
A review of cardiac manifestations and predictors of outcome in patients with COVID - 19.COVID-19 患者的心脏表现和预后预测因素综述。
Heart Lung. 2020 Nov-Dec;49(6):848-852. doi: 10.1016/j.hrtlng.2020.04.019. Epub 2020 May 3.
2
COVID-19 presenting with immune thrombocytopenia: A case report and review of the literature.新型冠状病毒肺炎合并免疫性血小板减少症：一例病例报告及文献复习
J Med Virol. 2021 Jan;93(1):43-45. doi: 10.1002/jmv.26138. Epub 2020 Jun 29.
3
Managing sickle cell patients with COVID-19 infection: the need to pool our collective experience.管理新冠病毒感染的镰状细胞病患者：汇聚我们集体经验的必要性。
Br J Haematol. 2020 Jul;190(2):e86-e89. doi: 10.1111/bjh.16880. Epub 2020 Jun 11.
4
From Hematologist's desk: The effect of COVID-19 on the blood system.血液科医生手记：新型冠状病毒肺炎对血液系统的影响
Am J Hematol. 2020 Aug;95(8):E213-E215. doi: 10.1002/ajh.25849. Epub 2020 May 8.
5
Immune Thrombocytopenic Purpura in a Patient with Covid-19.一名新冠肺炎患者的免疫性血小板减少性紫癜
N Engl J Med. 2020 Apr 30;382(18):e43. doi: 10.1056/NEJMc2010472. Epub 2020 Apr 15.
6
Latest updates on COVID-2019: A changing paradigm shift.2019冠状病毒病的最新进展：范式的转变
J Med Virol. 2020 Jun;92(6):533-535. doi: 10.1002/jmv.25760. Epub 2020 Mar 20.
7
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
8
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
9
Immune Thrombocytopenia as a Presenting Manifestation of Tuberculosis- Challenge in Resource Constraint Settings.免疫性血小板减少症作为结核病的首发表现——资源受限环境下的挑战
J Clin Diagn Res. 2016 Oct;10(10):OD01-OD02. doi: 10.7860/JCDR/2016/20911.8612. Epub 2016 Oct 1.
10
Cortical vein thrombosis in a case of idiopathic thrombocytopenic purpura.特发性血小板减少性紫癜患者的皮质静脉血栓形成。
Platelets. 2015;26(4):374-5. doi: 10.3109/09537104.2014.898180. Epub 2014 Mar 28.
Zotero 插件